TGen and University of Wisconsin researchers published a study to make early cancer detection more available.
A deep dive into the proteins and protein activities of human tumors grown in mouse models expands the potential therapeutic pathways to treat medulloblastoma, according to a new study published in the Journal of Proteome Research.
The Translational Genomics Research Institute (TGen), and Stingray Therapeutics, Inc. of Dallas and Houston, Texas announced a Small Business Innovation Research (SBIR) accelerated direct to phase II award of $2 Million.
Arizona State University’s Edson College of Nursing and Health Innovation, Phoenix Children’s Hospital and the Translational Genomics Research Institute (TGen) announced yesterday they will partner on a new study along with Cincinnati Children’s focused on nonalcoholic fatty liver disease, or NAFLD, in Latino youth.
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced the appointment of Page Bachman, JD, as the Institute’s Senior Vice President of Human Resources and Chief People Officer.
PHOENIX, September 8, 2022 — The Translational Genomics Research Institute (TGen), part of City of Hope, one of the largest cancer research and treatment organizations in the United States, today announced a […]
Nonalcoholic fatty liver disease (NAFLD) is both increasingly common and potentially deadly; yet its causes remain poorly understood. Now, a collaborative team of researchers at the Translational Genomics Research Institute (TGen), part of City of Hope, and Temple University has uncovered a link between decreases in an enzyme that makes choline in the liver —an essential nutrient for humans— and severity of NAFLD.
The Translational Genomics Research Institute (TGen), part of City of Hope, today announced that industry veteran Kevin Campbell has been appointed the Institute’s Chief Information Officer.
Could the SARS-CoV-2 vaccine reawaken previous antibody responses and point the way to a universal coronavirus vaccine? A new analysis of the antibody response to a COVID-19 vaccine suggests the immune system’s past history with other coronaviruses, including those behind the common cold, shapes the patients response, according to a study published today in Cell Reports.
TGen and City of Hope investigators Kamel Lahouel and Cristian Tomasetti are working on study to help guide cancer treatment.